Codix Bio Ltd
- Company typePrivate
- Founded-
- HeadquartersNigeria, Nigeria
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Codix Bio Ltd firmographics
Firmographics- Name
- Codix Bio Ltd
- Legal name
- Codix Bio Ltd
- Website
- https://codixgroup.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Codix Bio Ltd industry classification
Industry- Product category
- Medical Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)
- akta.pro secondary industry
- Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)
Keywords
Where Codix Bio Ltd is headquartered
LocationHeadquarters
- HQ city
- Nigeria
- HQ country
- Nigeria
- HQ region
- Africa
Offices1 record
Markets served
Codix Bio Ltd business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels1 record
Codix Bio Ltd product offering
Product offeringCore offering
Codix Bio Ltd, as a subsidiary of Codix Group, supplies rapid diagnostic test kits for detecting silent-killer illnesses including diabetes, hypertension, and heart diseases across African markets. Through its affiliated Colexa Biosensor Nigeria entity, it also manufactures blood glucose meters and strips as the first such factory in Nigeria and Sub-Saharan Africa, representing global diagnostic leaders SD Biosensor and OSANG Healthcare.
Product overview
Codix Bio Ltd is a subsidiary of Codix Group, a health-tech company focused on diagnostic precision and innovation for cardio-metabolic care. The company's product portfolio centers on rapid diagnostic test kits for detecting diabetes, hypertension, and heart diseases, along with locally manufactured blood glucose meters and strips through Colexa Biosensor Nigeria (the 1st blood glucose meter/strips factory in Nigeria and Sub-Saharan Africa). The company has supplied over 100 million diagnostic kits and represents global diagnostic leaders like SD Biosensor and OSANG Healthcare. Codix Bio Ltd operates as part of this broader diagnostic ecosystem, contributing to the group's mission of accessible healthcare technology across Africa.
Differentiator
Problem solved
Functional benefit
Products and services
- Rapid Diagnostic Test Kits Rapid diagnostic test kits for detecting silent-killer illnesses including diabetes, hypertension, and heart diseases, sourced from global diagnostic manufacturers SD Biosensor and OSANG Healthcare and distributed across African healthcare markets.
- Colexa Biosensor Blood Glucose Meters and Strips Locally manufactured blood glucose monitoring meters and test strips produced at the first dedicated facility of its kind in Nigeria and Sub-Saharan Africa, addressing diabetes management needs across the region.
Companies that use Codix Bio Ltd
Customer profileSegments1 record
Ideal customer profiles1 record
Codix Bio Ltd technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Codix Bio Ltd partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- SD BiosensorcoreSD Biosensor is a global leader represented by Codix Group. Codix supplies Rapid Diagnostic Test kits and has grown from humble beginnings as importers to become pioneers of healthcare technology in Africa, representing this key global manufacturer.
- OSANG HealthcarecoreOSANG Healthcare is a global leader represented by Codix Group alongside SD Biosensor. This partnership enables Codix to offer a comprehensive portfolio of diagnostic solutions for diabetes, hypertension, and heart diseases across Africa.
- Colexa Biosensor LtdflagshipColexa Biosensor Ltd is the 1st of its kind Blood Glucose Meters and Strips factory in Nigeria and Sub-Saharan Africa, established through Codix's backward integration strategy. This represents a milestone revolution in African healthcare, symbolizing commitment to providing accessible, high-quality diagnostic tools locally.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Codix Bio Ltd competitors and assessment
Company assessmentRegional players
- Lancet Laboratories: Largest diagnostic laboratory network in Africa, headquartered in South Africa. Comparable as an African diagnostics services platform; represents the channel-side competition Codix Bio Ltd may face as African healthcare systems formalize diagnostic procurement.
Direct peers
- OSANG Healthcare: South Korean manufacturer of IVD devices and rapid diagnostic tests, including blood glucose monitoring products. Codix represents OSANG in Africa; comparable on product mix (glucose meters, strips, rapid tests) and emerging-market distribution model.
- Acon Laboratories: US-headquartered manufacturer of rapid diagnostic tests and personal diagnostics (glucose meters, strips, infectious-disease rapid tests). Direct product-line overlap with Codix Bio Ltd's portfolio and similar channel-driven international expansion model.
- SD Biosensor: South Korean global leader in rapid diagnostic test kits and IVD devices — the same product categories Codix Bio Ltd distributes in Africa. While Codix represents SD Biosensor as a partner, SD also sells comparable products globally and is the most direct product-line comparable.
Broad incumbents
- Roche Diagnostics: World-leading IVD and diagnostics player with deep coverage across immunoassays, clinical chemistry, and point-of-care. Comparable as a competitor and potential public-sector partner for African health-system tenders that Codix Bio Ltd also targets.
- bioMérieux: Global IVD incumbent specializing in microbiology and infectious-disease diagnostics with growing emerging-market presence. Comparable as a multinational diagnostics player competing for African hospital and public-health contracts.
- QuidelOrtho: Global diagnostics company with a strong rapid-test portfolio across infectious disease, women's health, and cardio-metabolic markers. Comparable on rapid-test product mix and channel-based international expansion.
- Abbott Diagnostics: Global diagnostics incumbent with the FreeStyle line of blood glucose monitoring products and a broad IVD portfolio. Comparable as a competitor in glucose monitoring and rapid diagnostics, particularly as Abbott expands point-of-care access across Africa.
Emerging players
- mPedigree: Africa-focused health-tech and pharmaceutical authentication/distribution platform. Comparable as a homegrown African health-tech player expanding technology-enabled access across the continent, with overlapping healthcare-distribution ambitions.
- Trivitron Healthcare: India-based medical-device and IVD manufacturer with strong emerging-market distribution. Comparable to Codix Bio Ltd as an emerging-market diagnostics platform combining manufacturing, distribution, and a focus on price-sensitive, high-burden disease segments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Codix Bio Ltd social profiles
Digital presenceCodix Bio Ltd financial estimates
Financial estimateRevenue estimate
Valuation estimate
Codix Bio Ltd leadership team
Management profileNumber of profiles
Profiles3 records
Codix Bio Ltd subsidiaries and ownership
Company hierarchySubsidiaries13 records
Codix Bio Ltd funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Codix Bio Ltd M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Codix Bio Ltd
What does Codix Bio Ltd do?
Codix Bio Ltd, as a subsidiary of Codix Group, supplies rapid diagnostic test kits for detecting silent-killer illnesses including diabetes, hypertension, and heart diseases across African markets. Through its affiliated Colexa Biosensor Nigeria entity, it also manufactures blood glucose meters and strips as the first such factory in Nigeria and Sub-Saharan Africa, representing global diagnostic leaders SD Biosensor and OSANG Healthcare.
Is Codix Bio Ltd a public or private company?
Codix Bio Ltd is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Codix Bio Ltd founded?
Codix Bio Ltd was founded in -1. It employs 1 to 10 people.
Where is Codix Bio Ltd based?
Codix Bio Ltd is headquartered in Nigeria, Nigeria, in the Africa region.
Who are Codix Bio Ltd's main competitors?
Lancet Laboratories is listed as a regional player. Direct peers are OSANG Healthcare, Acon Laboratories and SD Biosensor. Broad incumbents are Roche Diagnostics, bioMérieux, QuidelOrtho and Abbott Diagnostics. Emerging players are mPedigree and Trivitron Healthcare.
Does Codix Bio Ltd have an API?
No public API is recorded for Codix Bio Ltd.
What industry is Codix Bio Ltd in?
Codix Bio Ltd's product category is Medical Diagnostics. Its primary akta.pro industry code is CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests), with a secondary code of HLAHAAAC, Microbiology & Infectious Disease Diagnostics (Culture/ID/AST). Its NAICS code is 325413 and its SIC code is 2835.